Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06786078 · ClinicalTrials.gov registry record · NA
The Lily Device Trial
A NA study of Chemotherapy-induced Alopecia, sponsored by Luminate Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 85
- Enrollment target
- 5
- Study locations
NCT06786078 is a NA study of Chemotherapy-induced Alopecia that is actively recruiting participants, run by Luminate Medical. The registered enrollment target is 85 participants, above the 72-participant average among 4 other Chemotherapy-induced Alopecia trials with a reported enrollment target (18% higher). The trial reports 5 study locations across 3 states.
The verdict
NCT06786078, a NA study of Chemotherapy-induced Alopecia, is actively recruiting participants, sponsored by Luminate Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
- 5
- Study locations
Study Summary
The goal of this clinical trial is to test if the Lily Device works to reduce chemotherapy induced hair loss in patients. It will also learn about the safety of the Lily Device. The main questions it aims to answer is: * Do patient preserve their hair using the Lily Device after 4 cycles of chemotherapy, when hair preservation is a Grade ≤1 graded by an independent healthcare professional on the Common Terminology Criteria for Adverse Events (CTCAE)? * What is the subject incidence of Grade 1 or above Adverse Device Events (ADE's)?
Conditions Studied
Interventions
- DEVICE Lily Device
Study Locations (5)
New Jersey
- Inspira Health - Mullica Hills - Mullica Hill
- Inspire Health - Vineland - Vineland
New York
- Guthrie - Our Lady of Lourdes Memorial Hospital - Binghamton
- Clinical Research Alliance - Westbury
Pennsylvania
- Guthrie Sayer Medical Centre - Sayre
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2024-12-20 |
| Est. Completion | 2025-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06786078
The ClinicalTrials.gov registry entry for NCT06786078 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 72-participant average among 4 other Chemotherapy-induced Alopecia trials with a reported enrollment target (18% higher). The listed sponsor is Luminate Medical, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chemotherapy-induced Alopecia appearing as the primary indexed condition, and to 1 intervention - of which Lily Device is the first listed.
NCT06786078 reports 5 study locations spanning 3 distinct geographic areas - top geographies include New Jersey, New York, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06786078 about?
NCT06786078 is a clinical study titled "The Lily Device Trial". The goal of this clinical trial is to test if the Lily Device works to reduce chemotherapy induced hair loss in patients. It will also learn about the safety of the Lily Device. The main questions it aims to answer is: * Do patient preserve their hair using the Lily Device after 4 cycles of chemoth...
What is the current status of trial NCT06786078?
This trial is currently recruiting. It is a NA study. The enrollment target is 85 participants. The study started on 2024-12-20. Estimated completion is 2025-11.
What conditions does trial NCT06786078 study?
This clinical trial studies the following conditions: Chemotherapy-induced Alopecia.
What interventions are being tested in trial NCT06786078?
The interventions under investigation include: Lily Device (DEVICE).
Who is sponsoring clinical trial NCT06786078?
This trial is sponsored by Luminate Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06786078 being conducted?
This trial has 5 study locations across New Jersey, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chemotherapy-induced Alopecia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads)
RECRUITING · NA
-
Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss
RECRUITING · NA
-
CARE (Chemotherapy Alopecia REduction)
ACTIVE NOT RECRUITING · NA
-
Scalp Cooling in MBC
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.